Is Aminosyn 3.5% M, Sulfite Free Still in Shortage in 2026?

If you rely on parenteral nutrition, the ongoing amino acid product shortage has probably affected you — or at least made you anxious about your next supply delivery. Here's the current situation with Aminosyn 3.5% M, Sulfite Free in 2026 and what you can do about it.

The short answer: Yes, Aminosyn 3.5% M, Sulfite Free remains in limited supply in 2026. The American Society of Health-System Pharmacists (ASHP) continues to list amino acid products on its active shortage list, and the American Society for Parenteral and Enteral Nutrition (ASPEN) has published specific shortage management recommendations that were last updated in 2025.

Why Is Aminosyn 3.5% M, Sulfite Free Still Hard to Find?

The shortage of amino acid injection products is not a simple, one-cause problem. Multiple factors have converged to create persistent supply challenges:

Limited Manufacturing Base

Only a handful of companies manufacture sterile amino acid injections for the U.S. market. The primary manufacturers include Pfizer (Hospira) / ICU Medical for Aminosyn products and Baxter for alternatives like Travasol and Clinisol. When any single manufacturer has a production issue, the impact on the entire market is significant.

Recalls and Quality Issues

In 2023, ICU Medical issued a voluntary nationwide recall of Aminosyn II 15% due to particulate matter contamination. Recalls like this pull product off shelves and can take months to fully resolve. Even after production resumes, it takes time to rebuild inventory across the supply chain.

The IV Supply Chain Crisis

The broader IV fluid and sterile product supply chain has been under pressure since late 2024, when hurricane damage to manufacturing facilities in the southeastern United States disrupted production. Although Aminosyn is not a basic IV fluid, it shares manufacturing infrastructure and distribution channels with products like saline and dextrose.

Rising Demand

More patients are receiving parenteral nutrition than ever before. An aging population, advances in surgical care, and increased survival of premature infants have all contributed to growing demand for amino acid products.

For a deeper dive into the reasons behind the shortage, see: Why Is Aminosyn 3.5% M, Sulfite Free So Hard to Find?

What Does Aminosyn 3.5% M, Sulfite Free Cost in 2026?

The cost of Aminosyn 3.5% M, Sulfite Free varies depending on where you get it and your insurance coverage. Here's what patients are seeing:

• Cash price: Approximately $72 for a supply of 6,000 mL (six 1,000 mL bags) of the 3.5% formulation with electrolytes
• Per-unit cost: About $0.01 per mL, or roughly $12 per bag
• Home infusion costs: The total cost of home parenteral nutrition — which includes the amino acid solution plus dextrose, lipids, vitamins, trace elements, supplies, pump rental, and nursing visits — can range from $200 to $500+ per day, with amino acids being just one component

Most patients receiving parenteral nutrition have the cost covered under their medical insurance benefit (not pharmacy benefit). Medicare covers home parenteral nutrition under Part B when specific criteria are met. For more on managing costs, see: How to Save Money on Aminosyn 3.5% M, Sulfite Free.

Are There New Options Available?

While no entirely new amino acid products have entered the U.S. market recently, there are developments worth noting:

• FDA compounding flexibilities: During shortage periods, the FDA has allowed compounding pharmacies — particularly 503B outsourcing facilities — to produce amino acid solutions that would normally require manufacturer approval. This has helped expand available supply.
• Multiple manufacturer sourcing: Home infusion pharmacies are increasingly working with multiple distributors and manufacturers to maintain supply. If one product is unavailable, they can often source an alternative.
• ASPEN shortage recommendations: ASPEN's 2025 guidance provides healthcare teams with specific strategies for managing amino acid shortages, including dose optimization, product substitution algorithms, and triage protocols for when supply is critically low.

If you're interested in alternatives, read our detailed guide: Alternatives to Aminosyn 3.5% M, Sulfite Free.

How to Find Aminosyn 3.5% M, Sulfite Free in Stock

Here are practical steps you can take right now:

1. Search on Medfinder. Visit medfinder.com to find pharmacies that currently have Aminosyn 3.5% M, Sulfite Free available.
2. Contact your home infusion pharmacy early. Don't wait until you're down to your last bag. Communicate supply concerns to your pharmacy as early as possible.
3. Ask your doctor about a backup plan. Have a conversation now about which alternative amino acid products would be appropriate for you. Getting an alternative prescription written in advance can save valuable time during a supply disruption.
4. Check multiple pharmacies. Home infusion pharmacies differ in their distributor relationships. If one can't source your product, another might be able to.
5. Stay informed. Monitor the ASHP drug shortage database and check back on Medfinder for availability updates.

For more detailed tips, see: How to Find Aminosyn 3.5% M, Sulfite Free in Stock Near You.

Final Thoughts

The Aminosyn 3.5% M, Sulfite Free shortage is ongoing in 2026, but it's not hopeless. Supply is limited rather than completely unavailable, and multiple alternative amino acid products exist. The key is staying proactive — communicating early with your healthcare team, planning ahead, and using tools like Medfinder to locate available supply.

If you're a healthcare provider looking for clinical guidance on managing this shortage, see our provider shortage briefing.